NYSE - Delayed Quote USD

Inspire Medical Systems, Inc. (INSP)

Compare
193.23 +5.52 (+2.94%)
At close: August 9 at 4:00 PM EDT
193.50 +0.27 (+0.14%)
After hours: August 9 at 6:25 PM EDT
Loading Chart for INSP
DELL
  • Previous Close 187.71
  • Open 189.01
  • Bid 172.00 x 900
  • Ask 195.23 x 800
  • Day's Range 186.52 - 196.55
  • 52 Week Range 123.00 - 257.40
  • Volume 651,554
  • Avg. Volume 654,517
  • Market Cap (intraday) 5.762B
  • Beta (5Y Monthly) 1.31
  • PE Ratio (TTM) 920.14
  • EPS (TTM) 0.21
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 222.31

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

www.inspiresleep.com

1,011

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INSP

View More

Performance Overview: INSP

Trailing total returns as of 8/9/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INSP
5.01%
S&P 500
12.04%

1-Year Return

INSP
21.13%
S&P 500
18.78%

3-Year Return

INSP
9.60%
S&P 500
20.46%

5-Year Return

INSP
196.73%
S&P 500
81.89%

Compare To: INSP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INSP

View More

Valuation Measures

Annual
As of 8/9/2024
  • Market Cap

    5.76B

  • Enterprise Value

    5.35B

  • Trailing P/E

    920.14

  • Forward P/E

    250.00

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.09

  • Price/Book (mrq)

    9.03

  • Enterprise Value/Revenue

    7.58

  • Enterprise Value/EBITDA

    540.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.85%

  • Return on Assets (ttm)

    -1.33%

  • Return on Equity (ttm)

    1.03%

  • Revenue (ttm)

    705.71M

  • Net Income Avi to Common (ttm)

    6.01M

  • Diluted EPS (ttm)

    0.21

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    439.66M

  • Total Debt/Equity (mrq)

    3.84%

  • Levered Free Cash Flow (ttm)

    -16.73M

Research Analysis: INSP

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

167.00 Low
222.31 Average
193.23 Current
270.00 High
 

Company Insights: INSP

People Also Watch